FCP
ABT icon

Fidelis Capital Partners’s Abbott ABT Stock Holding History

Fidelis Capital Partners’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.01M Sell
19,610
-8,912
-31% -$1.01M 0.14% 123
2025
Q4 		$3.57M Buy
28,522
+1,992
+8% +$254K 0.26% 80
2025
Q3 		$3.55M Buy
26,530
+6,240
+31% +$819K 0.28% 73
2025
Q2 		$2.66M Buy
20,290
+95
+0.5% +$12.5K 0.24% 74
2025
Q1 		$2.6M Buy
20,195
+226
+1% +$28.8K 0.28% 73
2024
Q4 		$2.57M Buy
19,969
+1,332
+7% +$154K 0.26% 74
2024
Q3 		$2.18M Buy
18,637
+2,254
+14% +$247K 0.26% 77
2024
Q2 		$1.8M Sell
16,383
-1,340
-8% -$142K 0.26% 76
2024
Q1 		$2.01M Sell
17,723
-253
-1% -$29K 0.31% 63
2023
Q4 		$1.98M Buy
17,976
+3,382
+23% +$338K 0.44% 50
2023
Q3 		$1.41M Buy
14,594
+317
+2% +$33.3K 0.48% 46
2023
Q2 		$1.56M Buy
14,277
+386
+3% +$41.1K 0.57% 40
2023
Q1 		$1.55M Buy
13,891
+8,720
+169% +$921K 0.66% 37
2022
Q4 		$580K Buy
+5,171
New +$535K 0.68% 47

Other funds holding ABT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelis Capital Partners's ABT Position: Q1 2026 in Review

Fidelis Capital Partners reduced its Abbott (ABT) stake by 31% in Q1 2026, selling an estimated $1.01M and leaving 19,610 shares worth $2.01M. The position accounts for 0.14% of the portfolio, ranked #123.

Fidelis Capital Partners first reported a position in ABT in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.57M in Q4 2025. 3,087 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Fidelis Capital Partners held 19,610 shares of Abbott worth $2.01M as of Q1 2026.
  • Fidelis Capital Partners sold 8,912 Abbott shares in Q1 2026, an estimated $1.01M.
  • Abbott made up 0.14% of Fidelis Capital Partners's portfolio in Q1 2026, its #123 holding.
  • Fidelis Capital Partners first reported a position in Abbott in Q4 2022 and has held it in 14 quarters since.
  • Fidelis Capital Partners's Abbott position peaked at $3.57M in Q4 2025.
  • 3,087 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.